Fig. 1

ROC curves based on OS parameters contributing to nAMD and resistant male nAMD. A, B, and C compare overall nAMD patients with control subjects; D, E, and F compare resistant male nAMD patients with effective male nAMD patients. A and D show d-ROM levels, B and E show BAP levels, and C and F show SAF levels